恆指跌幅擴至逾300點 金融及石油股領跌 匯控及中海油續挫3%-5%
美債息由高位回落,美股三大指數昨晚在各類股份全面受捧下急升2%-3%。不過,美股期貨全面反覆回軟,日經由高位29,996,掉頭倒跌1%報29,376;滬指也倒跌1%半日收3,516。
恆指繼昨天回升1.4%曾高見29,550後,今早在昨天港交所(00388.HK)、騰訊(00700.HK)及美團(03690.HK)分別高開1.5%、2.2%及5.8%帶動,高開255點或0.9%報29,708,最多升313點至29,765無以為繼,接近11時倒跌,現造29,151,倒跌301點或1%,成交額1,295億元。
藍籌股普遍反覆受壓,尤其是「三桶油」挫3%-4.8%,中海油(00883.HK)最傷,股價三連跌,報8.71元,續挫4.8%,股價跌破20天線。
匯控(00005.HK)三連跌,今早股價跌3%報44.7元,暫守穩20天線(44.15元)之上;友邦(01299.HK)及中國平安(02318.HK)跌近2.6%及1.8%,分別報97.35元及94元。恆生(00011.HK)及建行(00939.HK)反覆跌逾1%,分別報145.9元及6.06元。
中移動(00941.HK)及聯通(00762.HK)也吐近2%及3%,分別報55.25元及4.99元。此外,濠賭股銀娛(00027.HK)跌2.7%報70.45元,股價失守10天線;金沙(01928.HK)也倒跌逾2%,報35.85元,股價失守10天線。至於傳統地產股跌近1%-2%,新世界(00017.HK)沽壓最大報37.8元。
內需股以蒙牛(02319.HK)沽壓較大,報42元,跌2.4%。不過,萬洲(00288.HK)升2.3%報7.02元。創科(00669.HK)升3%報125.5元。共同研發癌症藥品3期臨床試驗錄優異結果的中生(01177.HK)升4.2%報9.02元。此外,重磅股騰訊、美團及港交所僅續升1.3%、1.1%及0.6%,分別報706元、370.8元及492.4元。小米(01810.HK)升1.9%報26.3元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.